Comparison of a Novel Formulation of Abiraterone Acetate vs. the Originator Formulation in Healthy Male Subjects: Two Randomized, Open-Label, Crossover Studies
Crossref DOI link: https://doi.org/10.1007/s40262-017-0536-2
Published Online: 2017-04-19
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Goldwater, Ronald
Hussaini, Azra
Bosch, Bill
Nemeth, Paul
Funding for this research was provided by:
Churchill Pharmaceuticals LLC
License valid from 2017-04-19